Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2005;112:I-453-I-457
doi: 10.1161/CIRCULATIONAHA.104.524421
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matsunaga, A.
Right arrow Articles by Duran, C. M. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matsunaga, A.
Right arrow Articles by Duran, C. M. G.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Heart Attack
Related Collections
Right arrow CV surgery: valvular disease
Right arrow CV surgery: other
Right arrow Chronic ischemic heart disease

(Circulation. 2005;112:I-453 – I-457.)
© 2005 American Heart Association, Inc.


Surgery for Valvular Heart Disease

Progression of Tricuspid Regurgitation After Repaired Functional Ischemic Mitral Regurgitation

Akira Matsunaga, MD; Carlos M. G. Duran, MD, PhD

From The International Heart Institute of Montana Foundation at Saint Patrick Hospital and Health Sciences Center and The University of Montana (C.M.G.D.), Missoula, Mont; and the Department of Anesthesiology and Clinical Care Medicine (A.M.), Kasoshima University, Japan.

Correspondence to Carlos M.G. Duran, MD, PhD, The International Heart Institute of Montana, 554 W Broadway, Missoula, MT 59802. E-mail duran{at}saintpatrick.org

Background— Despite correction of left-sided cardiac lesions, associated functional tricuspid regurgitation (TR) that was surgically ignored can persist. It can also appear de novo. The aim of this study was to analyze TR in a group of patients who underwent successful revascularization and mitral valve repair (MVRep) for functional ischemic mitral regurgitation (MR).

Methods and Results— Among 124 consecutive patients with MVRep, 70 left the operating room with MR ≤1+ and had a preoperative and follow-up transthoracic echocardiogra. Moderate or greater MR or TR was considered significant. Twenty-one patients (30%) had TR before surgery, and only 9 had TR repaired. The postoperative incidence of residual TR was not significantly different whether the tricuspid valve had been repaired (4 of 9 [44%]) or surgically ignored (8 of 12 [67%]). At last follow-up, 34 patients (49%) had significant TR. The incidence of TR increased from 25% at <1 year to 53% between 1 and 3 years and 74% at >3 years. Absence or presence of recurrent MR did not significantly affect TR (14 of 22 [64%] with MR versus 20 of 48 [42%] with no MR). Preoperative and postoperative tricuspid annulus size in patients with late TR was significantly larger than in patients without TR.

Conclusions— Functional TR is frequently associated with functional ischemic MR. After MVRep, close to 50% of patients have TR. The incidence of postoperative TR increases with time. Preoperative tricuspid annulus dilation might be a predictor of late TR.


Key Words: valves • regurgitation • ischemia • mitral valve • tricuspid valve




This article has been cited by other articles:


Home page
CirculationHome page
J. H. Rogers and S. F. Bolling
The Tricuspid Valve: Current Perspective and Evolving Management of Tricuspid Regurgitation
Circulation, May 26, 2009; 119(20): 2718 - 2725.
[Abstract] [Full Text] [PDF]